• Skip to main content

Parkinson’s Treatment Report

www.ParkinsonsTreatmentReport.com

VY-AADC02

Phase 2 Trial of Gene Therapy, VY-AADC02, for Advanced Parkinson’s Enrolling in US

September 24, 2019

Phase 2 Trial of Gene Therapy, VY-AADC02, for Advanced Parkinson’s Enrolling in US

Phase 2 Trial of Gene Therapy, VY-AADC02, for Advanced Parkinson’s Enrolling in US

VY-AADC02 for Parkinson’s Disease With Motor Fluctuations

May 20, 2019

https://clinicaltrials.gov/ct2/show/NCT03562494?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F06%2F2019&lupd_d=14&sort=nwst

STUDY TITLE:
VY-AADC02 for Parkinson’s Disease With Motor Fluctuations

DESCRIPTION:
Condition:   Parkinson Disease
Interventions:   Biological: VY-AADC02;   Other: Placebo
Sponsors:   Neurocrine Biosciences;   Voyager Therapeutics
Recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT03562494

FIRST POSTED:
Tue, 19 Jun 2018 12:00:00 EDT

LAST UPDATE POSTED:
05/20/19 07:34AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03562494?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F06%2F2019&lupd_d=14&sort=nwst

Powered by Urgent Research

Copyright © 2025 Urgent Research